Immunic IMUX 深 沪
等待开盘 05-12 09:30:00 美东时间
11.99
+0.360
+3.10%
华盛通- 最 高12.24
- 今 开11.62
- 成交量 7.75万股
- 最 低 10.41
- 昨 收 11.63
- 总市值 36.62万
- 52周最高 12.24
- 市盈率 静 --
- 换手率 253.76%
- 52周最低 0.5062
- 委 比 -45.99%
- 总股本 3.05万
- 历史最高 28.99
- 量 比 0.77
- 振 幅 15.74%
- 历史最低 0.5062
- 每 手 1
- 风险率 1.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Immunic's Next-Gen Oral Multiple Sclerosis Drug Poised To Capture Share, Analyst Says
Stifel initiates coverage on Immunic (IMUX) with a Buy rating. Analysts see potential for VidoCa to disrupt the MS market via better safety.
04-18 02:20
D. Boral Capital Downgrades Immunic to Hold
D. Boral Capital analyst Jason Kolbert downgrades Immunic (NASDAQ:IMUX) from Buy to Hold.
04-15 20:24
Immunic Stock Jumps After Pricing $400 Million Private Placement
Immunic Inc (NASDAQ:IMUX) is surging Friday after the late‑stage biotech announced a private placement of up to $400 million.
02-14 00:25
EF Hutton Initiates Coverage On Immunic with Buy Rating, Announces Price Target of $17
EF Hutton analyst Jason Kolbert initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Target of $17.
2024-09-16 20:25
B. Riley Securities Initiates Immunic at Buy With $6 Price Target
05:47 AM EDT, 08/27/2024 (MT Newswires) -- Immunic (IMUX) has an average outperform rating and a price target range of $5 to $28, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Eu...
2024-08-27 17:47
